not tagged
not tagged
[]
kaeley et al. evaluation of success of ra treatment. 69% lda, 17% mda, 14% hda. common barriers - medication access 27%, non-adherence 20%, co-morbidities 20%, non-inflammatory pain 13% #acr22 abstr#0077 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC